Retatrutide Cut Knee Pain by Half in 63% to 70% of Patients

Northwestern University's Eli Lilly-funded phase 3 trials found 63% to 70% of participants on higher retatrutide doses halved knee pain; the highest dose cut body weight 24% on average.